Dibenzo-alpha-pyrones for Body Weight Gain Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective solutions for promoting weight loss or preventing weight gain, particularly in obese mammals with Type 2 diabetes mellitus, and there is a need to understand the pharmacological role of dibenzo-alpha-pyrones (DBPs) in body weight regulation.
Innovation Solution
Administration of 3-hydroxy-dibenzo-alpha-pyrone and 3,8-dihydroxy-dibenzo-alpha-pyrone compositions to mammals, which are shown to decrease body weight gain and potentially treat or prevent excess body weight, with gene expression studies indicating specific pathways influenced by these compounds.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current weight loss methods are used, then weight management is attempted, but they lack effectiveness particularly in obese mammals with Type 2 diabetes mellitus
Solution Approach 1:
The patent changes the chemical parameter by introducing specific dibenzo-alpha-pyrone compounds (3-hydroxy-dibenzo-alpha-pyrone and 3,8-dihydroxy-dibenzo-alpha-pyrone) with defined molecular structures and properties. These compounds exhibit weight loss effects particularly in obese mammals with Type 2 diabetes, representing a parameter change from conventional weight loss methods to phytochemical-based intervention.
2Quantity of substance
If dibenzo-alpha-pyrones are administered, then body weight gain is reduced, but the mechanism of action requires further understanding through gene expression studies
Solution Approach 1:
The patent incorporates gene expression analysis as a feedback mechanism to understand how dibenzo-alpha-pyrones affect weight regulation. By examining gene expression changes in response to compound administration, the research creates a feedback loop that links observed weight loss effects with molecular mechanisms, thereby reducing the loss of information about pharmacological action.
Data Source
AI summary
A method of using dibenzo-alpha-pyrones (DBPs) is provided wherein a subject is administered one or more of the aforementioned resulting in decreased body weight gain. In an embodiment, a 3-OH-DBP, 3,8-(OH)2-DBP, or a combination thereof is administered to an individual to control body weight gain.